Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Vaccine

• Publication date

  2001-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(00)00395-9PMID 11166898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong.

  2000cited by this paper
• Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

  1999cited by this paper
• A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans

  1999cited by this paper
• Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts.

  1999cited by this paper
• Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays

  1999cited by this paper
• Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997.

  1999cited by this paper
• Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness.

  1998cited by this paper
• Comparisons of Highly Virulent H5N1 Influenza A Viruses Isolated from Humans and Chickens from Hong Kong

  1998cited by this paper
• Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

  1998cited by this paper
• avian influenza virus

  1997cited by this paper
• Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults.

  1996cited by this paper
• Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

  1996cited by this paper
• Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model.

  1995cited by this paper
• Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults.

  1995cited by this paper
• Potential for transmission of avian influenza viruses to pigs.

  1994cited by this paper
• Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines.

  1983cited by this paper
• Replication of avian influenza A viruses in mammals

  1981cited by this paper

• Vaccine and Treatment Evaluation Units: A Historical Perspective.

  2025cites this paper
• Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network.

  2025cites this paper
• An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus.

  2024cites this paper
• Development of Virus-like Particle Plant-Based Vaccines against Avian H5 and H9 Influenza A Viruses

  2024cites this paper
• Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model

  2024cites this paper
• H5N1 Avian Influenza: Global Circulation and Response Strategies

  2024cites this paper
• Avian Influenza Virus A(H5Nx) and Prepandemic Candidate Vaccines: State of the Art

  2024cites this paper
• Influenza virus immune imprinting dictates the clinical outcomes in ferrets challenged with highly pathogenic avian influenza virus H5N1

  2023cites this paper
• Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo

  2023cites this paper
• Influenza vaccine: a review on current scenario and future prospects

  2023cites this paper
• Improving cross-protection against influenza virus in mice using a nanoparticle vaccine of mini-HA.

  2022cites this paper
• Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.

  2022cites this paper
• Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine. [version 1; peer review: awaiting peer review]

  2022cites this paper
• Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.

  2022cites this paper
• Broadly-reactive IgG responses to heterologous H5 prime-boost influenza vaccination are shaped by antigenic relatedness to priming strains

  2021cites this paper
• An Overview of Influenza Viruses and Vaccines

  2021cites this paper
• Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains

  2021cites this paper
• Immune Imprinting in the Influenza Ferret Model

  2020cites this paper
• Live Attenuated Influenza Vaccines for Pandemic Preparedness.

  2020cites this paper
• Influenza vaccine efficacy induced by orally administered recombinant baculoviruses

  2020cites this paper
• Characterization of thermostable Newcastle disease virus recombinants expressing the hemagglutinin of H5N1 avian influenza virus as bivalent vaccine candidates.

  2020cites this paper
• A conserved multi-epitope-based vaccine designed by targeting hemagglutinin protein of highly pathogenic avian H5 influenza viruses

  2020cites this paper
• Cross-reactive anti-hemagglutinin (HA) IgG responses are shaped by previous long-interval monovalent H5 vaccination and highly correlated with HA antigenic distance

  2020cites this paper
• Production of Recombinant HA1 subunit from H5N1 Avian Influenza Hemagglutinin in Escherichia coli

  2020cites this paper
• Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact

  2020cites this paper
• Immunization with Plant-Derived Multimeric H5 Hemagglutinins Protect Chicken against Highly Pathogenic Avian Influenza Virus H5N1

  2020cites this paper
• Innate immunemodulator containing adjuvant formulated HA based vaccine protects mice from lethal infection of highly pathogenic avian influenza H5N1 virus.

  2020cites this paper
• Low-dose influenza vaccine Grippol Quadrivalent with adjuvant Polyoxidonium induces a T helper-2 mediated humoral immune response and increases NK cell activity.

  2020cites this paper
• Human cell-based in vitro systems for vaccine evaluation

  2019cites this paper
• How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines

  2019cites this paper
• Continuous Readout versus Titer-Based Assays of Influenza Vaccine Trials: Sensitivity, Specificity, and False Discovery Rates

  2019cites this paper
• Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans

  2019cites this paper
• Influenza A(H5N1) Virus Subunit Vaccine Administered with CaPNP Adjuvant Induce High Virus Neutralization Antibody Titers in Mice

  2019cites this paper
• All-Trans Retinoic Acid Enhances Antibody Production by Inducing the Expression of Thymic Stromal Lymphopoietin Protein

  2018cites this paper
• 31 – Inactivated Influenza Vaccines

  2018cites this paper
• AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization

  2018cites this paper
• Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis

  2018cites this paper
• Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes

  2018cites this paper
• Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza

  2018cites this paper
• Pandemic influenza vaccines: what they have taught us about B cell immunology.

  2018cites this paper
• Vaccine With MF59 Adjuvant A Randomized Clinical Trial

  2017cites this paper
• A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines

  2017cites this paper
• Advancing new vaccines against pandemic influenza in low-resource countries.

  2017cites this paper
• A consensus-hemagglutinin-based vaccine delivered by an attenuated Salmonella mutant protects chickens against heterologous H7N1 influenza virus

  2017cites this paper
• Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.

  2017cites this paper
• Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response

  2017cites this paper
• Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice.

  2017cites this paper
• Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine

  2017cites this paper
• Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity

  2017cites this paper
• Immune Responses Induced by Recombinant Bacillus Subtilis Expressing the Hemagglutinin Protein of H5N1 in chickens

  2016cites this paper
• Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.

  2016cites this paper
• Attenuated Strains of Salmonella enterica Serovars Typhi and Paratyphi as Live Oral Vaccines Against Enteric Fever

  2016cites this paper
• Clinical testing of an inactivated influenza A/H5N1 vaccine candidate in a double-blinded, placebo-controlled, randomized trial in healthy adults in Vietnam.

  2016cites this paper
• Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection

  2016cites this paper
• Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

  2016cites this paper
• Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice.

  2016cites this paper
• Safety and Immunogenicity of a Baculovirus- Expressed Hemagglutinin Influenza Vaccine

  2016cites this paper
• Protective efficacy of a prime-boost protocol using H5-DNA plasmid as prime and inactivated H5N2 vaccine as the booster against the Egyptian avian influenza challenge virus.

  2016cites this paper
• Vaccine Prepandemic Priming on CD 4 + T-Cell Responses

  2015cites this paper
• High level expression and purification of hemagglutinin subtype H9 of influenza virus

  2015cites this paper
• Analysis of Influenza Vaccines

  2015cites this paper
• Cell mediated immunity to meet the avian influenza A ( H 5 N 1 ) challenge

  2015cites this paper
• Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites

  2015cites this paper
• Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.

  2015cites this paper
• Recombinant hemagglutinin protein vaccine: a new option in immunization against influenza

  2015cites this paper
• Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

  2015cites this paper
• Influenza vaccines: challenges and solutions.

  2015cites this paper
• Refining the approach to vaccines against influenza A viruses with pandemic potential.

  2015cites this paper
• An Anti-H5N1 Influenza Virus FcDART Antibody Is a Highly Efficacious Therapeutic Agent and Prophylactic against H5N1 Influenza Virus Infection

  2015cites this paper
• Characterization of Functional Antibody and Memory B-Cell Responses to pH1N1 Monovalent Vaccine in HIV-Infected Children and Youth

  2015cites this paper
• Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets.

  2015cites this paper
• Influenza vaccines: from whole virus preparations to recombinant protein technology

  2014cites this paper
• Vaccines for preventing influenza in healthy adults.

  2014cites this paper
• Pandemic preparedness against highly pathogenic avian influenza viruses

  2014cites this paper
• Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.

  2014influential citation
• Effect of Influenza A(H5N1) Vaccine Prepandemic Priming on CD4+ T-Cell Responses

  2014cites this paper
• Expanding the options for confronting pandemic influenza.

  2014cites this paper
• Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms

  2014cites this paper
• A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

  2014cites this paper
• Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children

  2014cites this paper
• Tetrahymena thermophila: An expression platform for the production of viral antigens

  2014cites this paper
• Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant

  2014cites this paper
• Construction of Recombinant Baculovirus Expressing HA Protein of Egyptian H5N1 Avian Influenza Virus

  2014cites this paper
• Insect cell surface expression of hemagglutinin (HA) of Egyptian H5N1 avian influenza virus under transcriptional control of whispovirus immediate early-1 promoter.

  2014cites this paper
• Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

  2014cites this paper
• Development of live attenuated influenza vaccines against pandemic influenza strains

  2014cites this paper
• Expression of Avian Influenza Virus (H5N1) Hemagglutinin and Matrix Protein 1 in Pichia pastoris and Evaluation of their Immunogenicity in Mice

  2014cites this paper
• Immunogenicity and efficacy of a recombinant adenovirus expressing hemagglutinin from the H5N1 subtype of swine influenza virus in mice.

  2014cites this paper
• jmbReview Insect Cell Surface Expression of Hemagglutinin ( HA ) of Egyptian H 5 N 1 Avian Influenza Virus Under Transcriptional Control of Whispovirus Immediate Early-1 Promoter

  2014cites this paper
• Vaccines for preventing influenza in healthy adults.

  2014cites this paper
• Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines.

  2013cites this paper
• CD4 T Cell Help Is Limiting and Selective during the Primary B Cell Response to Influenza Virus Infection

  2013cites this paper
• 17 – Inactivated influenza vaccines

  2013cites this paper
• Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development

  2013cites this paper
• Towards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron

  2013cites this paper
• Immune responses of chickens inoculated with recombinant Lactobacillus expressing the haemagglutinin of the avian influenza virus

  2013cites this paper
• Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.

  2013cites this paper
• Cross-Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines

  2013cites this paper
• Clinical vaccine development for H5N1 influenza

  2013cites this paper
• Comparison of protection against H5N1 influenza virus in mouse offspring provided by maternal vaccination with HA DNA and inactivated vaccine

  2013cites this paper